Marnix Geukes Foppen

Author

Also Known As

M. Geukes Foppen, Marnix Geukes Foppen

Publications

958

Citations

H-Index

Concepts

All Affiliations

Marnix Geukes Foppen is an author at The Netherlands Cancer Institute specializing in immunology, immunotherapy, and medicine.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	406
2	Immunology	4	4	406
3	Cell Biology	1	1	109
4	Pharmacology	1	1	215
5	Autoimmunity	1	1	109

Marnix Geukes Foppen

Publications

940

Citations

H-Index

Page 1

	Year	Citations
Baseline Peripheral Blood Biomarkers Associated with Clinical Outcome of Advanced Melanoma Patients Treated with Ipilimumab Alexander Martens, Kilian Wistuba‐Hamprecht, Marnix Geukes Foppen, Clinical Cancer Research	2016	534
Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors Julia Boshuizen, Louise A. Koopman, Oscar Krijgsman, Nature Medicine Melanoma HeterogeneityAxl Antibody-drug ConjugateDrug TargetingMedicineMelanoma	2018	215
Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients Kilian Wistuba‐Hamprecht, Alexander Martens, Florian Heubach, European Journal of Cancer Tumor ImmunologyT-cells CorrelateCancer ImmunosurveillanceMelanomaImmunology	2017	109
Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab Kilian Wistuba‐Hamprecht, Alexander Martens, Karin Haehnel, European Journal of Cancer Cancer ImmunosurveillanceMedicineMelanomaHematologyImmunology	2016	66
LBA3 Treatment with tumor-infiltrating lymphocytes (TIL) versus ipilimumab for advanced melanoma: Results from a multicenter, randomized phase III trial John B.A.G. Haanen, M. Rohaan, T.H. Borch, Annals of Oncology Cancer ImmunosurveillanceLba3 TreatmentMedicineMelanomaImmunology	2022	16

Page 1